Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Estienne, V.
Right arrow Articles by Ruf, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Estienne, V.
Right arrow Articles by Ruf, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 14, No. 4, pp. 359-366, April 2002
© 2002 Japanese Society for Immunology

Analysis of a conformational B cell epitope of human thyroid peroxidase: identification of a tyrosine residue at a strategic location for immunodominance

Valérie Estienne1, Christine Duthoit1, Stéphanie Blanchin1, Roland Montserret2, Josée-Martine Durand-Gorde1, Martine Chartier3, Daniel Baty3, Pierre Carayon1 and Jean Ruf1

1 U555 INSERM/Laboratoire de Biochimie Endocrinienne et Métabolique, Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex 05, France 2 Pôle de BioInformatique Lyonnais, IBCP, UMR 5086 CNRS, 69367 Lyon Cedex 07, France 3 Laboratoire d’Ingénierie des Systèmes Macromoléculaires, IBSM, UPR 9027 CNRS, 13402 Marseille Cedex 20, France

Correspondence to: J. Ruf; E-mail: jean.ruf{at}medecine.univ-mrs.fr
Transmitting editor: E. Möller

Thyroid peroxidase (TPO) is involved in autoimmune thyroid diseases and high titers of TPO autoantibodies directed to various conformational B cell epitopes are frequently present in patients’ sera. Deciphering these epitopes is a difficult task, but can give insight into the structural basis of autoimmune recognition. TPO is a membrane-bound enzyme with the extracellular part organized in three protein domains, but of unknown three-dimensional structure. We previously localized a TPO B cell epitope within amino acid residues 742–848, a region encompassing the two C-terminal, extracellular domains of the protein. We found that at least one of the three tyrosine residues of the peptide 742–848 might be involved in autoantibody binding. In this study, we show by site-directed mutagenesis that the autoepitope contains tyrosine 772 located near the hinge area between the two protein domains, suggesting they are both involved in the epitope structure. The B cell epitopes of TPO are clustered in two overlapping immunodominant regions. To map the newly localized epitope with respect of these regions, competition experiments were performed using a reference panel of TPO mAb and a further mAb previously found to be specific for the TPO peptide 742–848 at variance with all the other ones. Here, we show that the tyrosine 772-bearing epitope in the peptide 742–848 maps in a region that partly overlaps the reported two immunodominant regions. These results are suggestive of a complex TPO folding that involves all the three TPO protein domains to form a highly conformational immunodominant region.

Keywords: autoimmunity, B cell epitope, circular dichroism, thyroid peroxidase, thyroperoxidase


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
G. Fenalti, C. S. Hampe, Y. Arafat, R. H.P. Law, J. P. Banga, I. R. Mackay, J. C. Whisstock, A. M. Buckle, and M. J. Rowley
COOH-Terminal Clustering of Autoantibody and T-Cell Determinants on the Structure of GAD65 Provide Insights Into the Molecular Basis of Autoreactivity
Diabetes, May 1, 2008; 57(5): 1293 - 1301.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. A. Rebuffat, D. Bresson, B. Nguyen, and S. Peraldi-Roux
The key residues in the immunodominant region 353-363 of human thyroid peroxidase were identified
Int. Immunol., July 1, 2006; 18(7): 1091 - 1099.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Bresson, S. A. Rebuffat, B. Nguyen, J. P. Banga, A. Gardas, and S. Peraldi-Roux
New Insights into the Conformational Dominant Epitopes on Thyroid Peroxidase Recognized by Human Autoantibodies
Endocrinology, June 1, 2005; 146(6): 2834 - 2844.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Bresson, M. Pugniere, F. Roquet, S. A. Rebuffat, B. N-Guyen, M. Cerutti, J. Guo, S. M. McLachlan, B. Rapoport, V. Estienne, et al.
Directed Mutagenesis in Region 713-720 of Human Thyroperoxidase Assigns 713KFPED717 Residues as Being Involved in the B Domain of the Discontinuous Immunodominant Region Recognized by Human Autoantibodies
J. Biol. Chem., September 10, 2004; 279(37): 39058 - 39067.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Bresson, M. Cerutti, G. Devauchelle, M. Pugniere, F. Roquet, C. Bes, C. Bossard, T. Chardes, and S. Peraldi-Roux
Localization of the Discontinuous Immunodominant Region Recognized by Human Anti-thyroperoxidase Autoantibodies in Autoimmune Thyroid Diseases
J. Biol. Chem., March 7, 2003; 278(11): 9560 - 9569.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Guo, S. M. McLachlan, and B. Rapoport
Localization of the Thyroid Peroxidase Autoantibody Immunodominant Region to a Junctional Region Containing Portions of the Domains Homologous to Complement Control Protein and Myeloperoxidase
J. Biol. Chem., October 18, 2002; 277(43): 40189 - 40195.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.